On May 28, 2024, Brian Roman, Chief Legal Officer of Viatris Inc (VTRS, Financial), executed a sale of 89,419 shares of the company. According to the SEC Filing, the transaction occurred at an average price of $10.38 per share, totaling approximately $928,209.42. Following this transaction, the insider now owns 67,723 shares of the company.
Viatris Inc (VTRS, Financial) is a global healthcare company that provides access to medicines, sustainable operations, and community health management. The company focuses on creating high-quality healthcare products and making them accessible to people around the globe.
Over the past year, Brian Roman has sold a total of 89,419 shares and has not made any purchases of the company's stock. The insider transaction history for Viatris Inc shows a total of 10 insider sells and no insider buys over the past year.
Shares of Viatris Inc were trading at $10.38 on the day of the transaction, giving the company a market cap of $12.36 billion. The stock is currently valued at a GF Value of $9.90, indicating a price-to-GF-Value ratio of 1.05, which suggests that the stock is Fairly Valued.
The GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
